missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MP Biomedicals™ Streptokinase
Catalyzes hydrolysis of amide linkages
Brand: MP Biomedicals™ 0210111410
This item is not returnable.
View return policy
Description
Forms a 1:1 complex with plasminogen which is then converted to streptokinase-plasmin. Both streptokinase-plasminogen and streptokinase-plasmin complexes can activate plasminogen.
- Can be used as a thrombolytic agent in therapy of ischemic stroke
- From: Lancefield group C strain of Streptococcus
- Presentation: White lyophilized powder
- Unit definition: Amount of enzyme that will liquefy a standard clot of fibrinogen, plasminogen and thrombin in 10 minutes at 37°C and pH 7.5
- Specific activity: >5,000 units/mg dry weight
- Solubility: Soluble in water
Specifications
| ≥5000 U/mg | |
| Used as a thrombolytic agent in the therapy of ischemic stroke | |
| Streptococcus species, lancefield group C strain | |
| Streptokinase | |
| Lyophilized Powder |
| White | |
| -20°C | |
| 10 kU | |
| 47400 |
Safety and Handling
Product Identifier
Signal Word
Hazard Category
Hazard Statement
Precautionary Statement
Supplemental information
- Streptokinase
Signal Word
- Danger
Hazard Category
- Respiratory sensitiser Category 1
Hazard Statement
- H334-May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary Statement
- P101-If medical advice is needed, have product container or label at hand.
- P102-Keep out of reach of children.
- P103-Read label before use.
- P261-Avoid breathing dust/fume/gas/mist/vapours/spray.
- P284-¢In case of inadequate ventilation! wear respiratory protection.
- P304+P340-IF INHALED: Remove person to fresh air and keep comfortable for breathing.
- P342+P311-If experiencing respiratory symptoms: Call a POISON CENTER/doctor/ .
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental information
- MIXTURE LIST-Contains : Streptokinase